Search all medical codes

EGFR (epidermal growth factor receptor) (eg, non-small cell lung cancer) gene analysis, common variants (eg, exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q)

CPT4 code

Name of the Procedure:

EGFR (Epidermal Growth Factor Receptor) Gene Analysis (Common Variants: Exon 19 LREA Deletion, L858R, T790M, G719A, G719S, L861Q)

Summary

The EGFR Gene Analysis is a laboratory test that examines specific mutations in the epidermal growth factor receptor (EGFR) gene. It is particularly important for patients with non-small cell lung cancer. By identifying these mutations, doctors can tailor treatments to the genetic profile of the tumor.

Purpose

The primary purpose of EGFR gene analysis is:
  • To identify mutations in the EGFR gene that are commonly associated with non-small cell lung cancer (NSCLC).
  • To help guide the selection of personalized cancer treatments, such as tyrosine kinase inhibitors (TKIs), which target specific EGFR mutations.

Indications

This test is indicated for patients who:
  • Have been diagnosed with non-small cell lung cancer.
  • Demonstrate symptoms or have clinical features suggesting the presence of EGFR mutations.
  • Have progressed after initial lung cancer treatments and require additional therapeutic guidance.

Preparation

Before the procedure, the patient should:
  • Provide a tissue or blood sample, which the healthcare provider will collect.
  • No specific fasting or medication adjustments are generally required unless specified by the healthcare team.
  • Complete any diagnostic imaging or biopsies as recommended by the oncologist to locate the tumor and plan the biopsy if necessary.

Procedure Description

The procedure involves:
  1. Sample Collection: A tissue biopsy or blood sample is obtained from the patient.
  2. DNA Extraction: DNA is extracted from the collected sample.
  3. PCR Amplification and Sequencing: Polymerase Chain Reaction (PCR) is used to amplify the EGFR gene, followed by DNA sequencing to identify specific mutations.
  4. Data Analysis: The generated data is analyzed to detect the presence of mutations such as exon 19 LREA deletion, L858R, T790M, G719A, G719S, and L861Q.

    Tools and Equipment:
    • Biopsy needles, syringes for sample collection.
    • PCR machines, sequencers, and specialized reagents for DNA analysis.
Anesthesia:
  • Local anesthesia may be used during tissue biopsy procedures.

Duration

The entire testing process, from sample collection to result analysis, typically takes a few days to a couple of weeks.

Setting

The sample collection occurs at a hospital, outpatient clinic, or specialized surgical center. The DNA analysis is conducted in a specialized laboratory.

Personnel

  • Oncologists and pulmonologists may order the test.
  • Pathologists and laboratory technicians perform the DNA extraction and analysis.
  • Nurses and radiologists are involved in the sample collection process.

Risks and Complications

  • Sample Collection Risks: Bleeding, infection, and pain at the biopsy site.
  • Procedural Risks: There are minimal risks directly from the genetic test itself, but incorrect sampling or handling can lead to inconclusive or false results.

Benefits

  • Personalized treatment plans can significantly improve patient outcomes.
  • Better response rates to targeted therapies based on the specific EGFR mutation.
  • Reduced exposure to ineffective treatments.

Recovery

  • Post-procedure care mainly applies to biopsy recovery, which may include managing soreness and monitoring for infection.
  • No recovery time is required for the genetic test itself, and patients can resume normal activities immediately.
  • Follow-up appointments with an oncologist are necessary to discuss the results and subsequent treatment plans.

Alternatives

  • Liquid Biopsy: A non-invasive alternative using blood samples to detect EGFR mutations.
  • Broad Genetic Testing Panels: These may assess multiple genes involved in cancer, not just EGFR.

    Pros and Cons:
  • Liquid Biopsy: Less invasive but might not be as comprehensive.
  • Broad Genetic Testing Panels: Provide extensive information, which can be beneficial but more costly and time-consuming.

Patient Experience

  • During the Procedure: Patients may feel discomfort or pain during a biopsy; however, local anesthesia helps manage these sensations.
  • After the Procedure: Mild soreness at the biopsy site; genetic testing itself involves no discomfort.
  • Pain Management: Pain relief may include over-the-counter pain medications and ice packs at the biopsy site. Comfort measures during the biopsy include numbness, local anesthesia, and supportive care by medical staff.

Similar Codes